News-Papers
Testimonial
Video Gallery
Octreotide: an active agent in epithelial ovarian carcinoma?
Published on Monday, 23 November 2015
See also Somatostatin in oncology, the overlooked evidences.
Search
Follow us...
Latest
- Modulation of Radiation-induced Base Excision Repair Pathway Gene Expression by Melatonin
- Melatonin, circadian rhythms and breast cancer
- Melatonin Modulation of Radiation and Chemotherapeutics-induced Changes on Differentiation of Breast Fibroblasts
- THERAPY WITH SOMATOSTATIN ANALOGUES IN PATIENTS WITH CASTRATION-REFRACTORY PROSTATE CANCER
- Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer (Review)
- Melatonin May Increase Anticancer Potential of Pleiotropic Drugs
- Melatonin inhibits growth of B16 melanoma in C57BL/6 mice
- Melatonin induces the apoptosis and inhibits the proliferation of human gastric cancer cells via blockade of the AKT/MDM2 pathway
- Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells
- Melatonin induces apoptosis through biomolecular changes, in SK-LU-1 human lung adenocarcinoma cells
- Melatonin Enhances the Usefulness of Ionizing Radiation: Involving the Regulation of Different Steps of the Angiogenic Process
- Melatonin enhances the apoptotic effects and modulates the changes in gene expression induced by docetaxel in MCF‑7 human breast cancer cells
- Exceptional and typical biomarker responses to AminoTriComplex in metastatic prostate cancer: a case series
- Dotatate PET/CT and 225Ac-Dotatate Therapy for Somatostatin Receptor-expressing Metastatic Breast Cancer
- Application of chitosan and its derivatives in immunotherapy of malignant neoplasms
- A 28-year prospective analysis of serum vitamin E, vitamin E-related genetic variation and risk of prostate cancer
- Melatonin as an adjuvant in radiotherapy for radioprotection and radiosensitization
- Melatonin as a Therapeutic Agent for the Inhibition of Hypoxia-Induced Tumor Progression: A Description of Possible Mechanisms Involved
Most Read
- The Di Bella Method (DBM)
- About melatonin - 1996
- All-trans-retinoic acid and cancer
- Biography
- The Di Bella Method Increases by the 30% the survival rate for Pancreas tumors and for this reason should be proposed as first line therapy for this type of cancer
- Chronic Lymphocytic Leukemia: 4 patients, long-lasting remission
- Somatostatin in oncology, the overlooked evidences
- Treatment of Low-grade Non-Hodgkin’s Lymphomas at Advanced Stage
- How effective is chemo therapy?
- Bibliography
- Complete objective response to biological therapy of plurifocal breast carcinoma
- Large B-cells Non-Hodgkin's Lymphoma, Stage IV-AE: a Case Report
- Non-Hodgkin's Lymphoma, Stage III-B-E: a Case Report
- Vademecum
- Frequently Asked Questions
- Declaration recommends eliminate the use of Impact factor for research evaluation
- Non–Small-Cell Lung Cancer Patients with Low Performance Status: study on 28 patients
- Breast cancer: study on 122 cases. The Di Bella Method (DBM) improved survival, objective response and performance status in a retrospective observational clinical study on 122 cases of breast cancer